The Role of Phosphatidylinositides in Lipid Metabolism
The Role of Phosphatidylinositides in Lipid Metabolism
批准号:
10065516
负责人:
Marisa Wong Medina
金额:
$42.04万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-12 至 2022-11-30
关键词:
AmericanAnimal ModelAnimalsAutophagocytosisAutophagosomeBackBindingBloodCardiometabolic DiseaseCell membraneCell modelCell surfaceCellsCholesterolDefectDevelopmentEarly EndosomeEndosomesEnzymesEukaryotic CellFamilyFatty acid glycerol estersFemaleFour Core GenotypesGoalsGonadal HormonesHeart DiseasesHepG2HepaticHepatocyteHormone useImpairmentIn VitroIntegral Membrane ProteinInvestigationKnock-outKnockout MiceLeadLipidsLipoproteinsLiverLow Density Lipoprotein ReceptorLow-Density LipoproteinsLysosomesMetabolic DiseasesMetabolismModelingMolecularMusNonesterified Fatty AcidsOculocerebrorenal SyndromePathway interactionsPhenotypePhosphatidylinositolsPhosphoric Monoester HydrolasesPlasmaPlayPloidiesProcessRecyclingRegulationRisk FactorsRoleSex ChromosomesStainsTestingTriglyceridesVesiclecardiometabolic riskcardiovascular disorder preventiondisorder riskfatty acid oxidationinhibitor/antagonistinositol-1,4,5-trisphosphate 5-phosphataseknock-downlipid biosynthesislipid metabolismmalemouse modelnon-alcoholic fatty liver diseasenovel therapeuticsoverexpressionreceptorreceptor recyclingsextherapeutic targettraffickinguptake
中文摘要
总结
作为细胞内运输的关键导向剂,磷脂酰肌醇(PI)是低丰度脂质家族,
影响真核细胞内的几乎每一个过程。低密度脂蛋白受体(LDLR),一种主要的
血液LDL水平的决定因素,是预防心血管疾病的最有效的治疗靶点。
疾病LDL结合后,细胞表面的LDLR被内化,在那里它释放结合的LDL,然后
返回到细胞表面或被引导到溶酶体进行降解。最近,我们发现敲门声-
跨膜蛋白55 B(TMEM 55 B),一种磷脂酰肌醇(4,5)二磷酸[PI(4,5)P]
磷酸酶,刺激细胞中LDLR蛋白的衰减,并升高小鼠血浆LDLC。因为PI(4,5)P是
我们假设PI(4,5)P磷酸酶(如TMEM 55 B)可能会改变
LDLC通过调节LDLR细胞内运输。我们还发现,PI(4,5)P磷酸酶的减少导致
严重损害甘油三酯向血浆中的分泌。值得注意的是,这发生在没有肝脏蓄积的情况下,
有趣的是,仅在雄性小鼠中观察到脂肪,而在雌性小鼠中没有影响。缺乏肝脏脂肪
积累可归因于许多不同的机制,包括增加的脂肪吞噬(一种过程
选择性自噬,其中脂滴被靶向用于溶酶体衰变)。PI(4,5)P是一种重要的调节剂
自噬体融合后溶酶体重组,我们发现TMEM 55 B敲低增加
溶酶体这些结果表明PI(4,5)P磷酸酶可能调节肝脏TG的分泌和储存
通过溶酶体依赖机制。因此,本建议的总体目标是评价
PI(4,5)P在LDLR再循环和TG分泌中的作用。在目标1中,我们将i)测试PI(4,5)P代谢酶是否影响
使用遗传修饰的小鼠模型在不存在LDLR的情况下评估血浆LDL; ii)评估修饰的影响,
PI(4,5)P对Ldlr细胞内水平和小鼠肝细胞中的定位的影响; iii)测试PI(4,5)P的酶促表达
无活性的Tmem 55 b挽救了在Tmem 55 b敲除小鼠中观察到的表型;和iv)评估
PI(4,5)P磷酸酶对LDLR再循环的调节依赖于已知的LDLR衰减调节剂。在目标2中
i)比较全身与肝脏特异性Tmem 55 b敲除雄性小鼠中的TG分泌,以确认
缺陷是一种肝脏机制; ii)测试是否缺乏肝脏脂肪积聚,如预期结果
在Tmem 55 b敲除小鼠的肝细胞中,TG分泌受损是由于脂肪酸
氧化、合成或摄取,或TG合成; iii)确定依赖于溶酶体的PI(4,5)P磷酸酶
iv)评估PI(4,5)P调节的性别特异性作用是否
TG分泌的减少是由于性染色体补体(XX与XY)和/或性腺激素。调查
PI(4,5)P在脂质和脂蛋白代谢中的作用可能导致新的治疗选择的发展
降低心脏代谢疾病的风险。
英文摘要
SUMMARY
As key directors of intracellular trafficking, phosphotidylinsotides (PIs) are a family of low abundance lipids that
impact almost every process within the eukaryotic cell. The low-density lipoprotein receptor (LDLR), a major
determinant of blood LDL levels, is the most efficacious therapeutic target for the prevention of cardiovascular
disease. Upon LDL binding, LDLR at the cell surface is internalized, where it releases the bound LDL and then
recycles back to the cell surface or is directed to the lysosome for degradation. Recently, we found that knock-
down of transmembrane protein 55B (TMEM55B), a phosphatidylinositol (4,5) bisphosphate [PI(4,5)P]
phosphatase, stimulated decay of LDLR protein in cells and raised plasma LDLC in mice. Since PI(4,5)P is
involved in lysosome formation, we hypothesize that PI(4,5)P phosphatases (such as TMEM55B) may alter
LDLC by regulating LDLR intracellular trafficking. We also found that reduction of PI(4,5)P phosphatases caused
severely impaired secretion of triglycerides into plasma. Notably, this occurred without the accumulation of liver
fat, and interestingly, was observed only in male mice, with no effect in females. The lack of hepatic fat
accumulation may be attributed to a number of different mechanisms including increased lipophagy (a process
of selective autophagy in which lipid droplets are targeted for lysosomal decay). PI(4,5)P is an important regulator
of lysosome reformation after autophagosome fusion, and we found that TMEM55B knock-down increased
lysosomes. These findings suggest that PI(4,5)P phosphatases may modulate hepatic TG secretion and storage
through a lysosome-dependent mechanism. Thus, the overall objective of this proposal is to evaluate the role of
PI(4,5)P in LDLR recycling and TG secretion. In Aim 1 we will i) Test if PI(4,5)P metabolizing enzymes impact
plasma LDL in the absence of LDLR using genetically modified mouse models; ii) Evaluate the effect of modifying
PI(4,5)P on Ldlr intracellular levels and localization in mouse hepatocytes; iii) Test if expression of enzymatically
inactive Tmem55b rescues the phenotypes observed in the Tmem55b knockout mouse; and iv) Evaluate if
PI(4,5)P phosphatase regulation of LDLR recycling is dependent on known regulators of LDLR decay. In Aim 2
we will i) Compare TG secretion in whole body versus liver-specific Tmem55b knockout male mice to confirm
that the defect is a hepatic mechanism; ii) Test if lack of hepatic fat accumulation, as would be expected to result
from impaired TG secretion, in hepatocytes from Tmem55b knockout mice is due to changes in fatty acid
oxidation, synthesis, or uptake, or TG synthesis; iii) Determine PI(4,5)P phosphatases depend on lysosome
and/or autophagosomes to impair TG secretion; and iv) Evaluate if the sex-specific effect of PI(4,5)P modulation
of TG secretion is due to the sex chromosome complement (XX vs. XY) and/or gonadal hormones. Investigation
of the role of PI(4,5)P in lipid and lipoprotein metabolism may lead to the development of new therapeutic options
for reducing cardiometabolic disease risk.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Mechanism of the Regulation of Plasma Cholesterol Levels by PI(4,5)P2.
PI(4,5)P2 调节血浆胆固醇水平的机制。
DOI:
10.1007/978-3-031-21547-6_3
发表时间:
2023
期刊:
Advances in experimental medicine and biology
影响因子:
--
作者:
[Qin,Yuanyuan, Medina,MarisaW]
通讯作者:
Medina,MarisaW
TMEM55B as a molecular determinant of NAFLD
-
批准号:10913882
-
项目类别:
-
资助金额:$59.1万
-
财政年份:2023
-
负责人:Marisa Wong Medina
-
依托单位:
Alternative Splicing in Regulation of Cholesterol Synthesis and Uptake
-
批准号:8114155
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2010
-
负责人:Marisa Wong Medina
-
依托单位:
Alternative Splicing in Regulation of Cholesterol Synthesis and Uptake
-
批准号:7949779
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2010
-
负责人:Marisa Wong Medina
-
依托单位:
Alternative Splicing in Regulation of Cholesterol Synthesis and Uptake
-
批准号:8471174
-
项目类别:
-
资助金额:$37.82万
-
财政年份:2010
-
负责人:Marisa Wong Medina
-
依托单位:
Alternative Splicing in Regulation of Cholesterol Synthesis and Uptake
-
批准号:8277365
-
项目类别:
-
资助金额:$39.72万
-
财政年份:2010
-
负责人:Marisa Wong Medina
-
依托单位:
Molecular Determinants of Statin Efficacy and Adverse Effects in Cellular Models
-
批准号:9139486
-
项目类别:
-
资助金额:$105.74万
-
财政年份:--
-
负责人:Marisa Wong Medina
-
依托单位:
海外基金